These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 34661502)

  • 21. Expression and prognostic impact of lncRNAs in acute myeloid leukemia.
    Garzon R; Volinia S; Papaioannou D; Nicolet D; Kohlschmidt J; Yan PS; Mrózek K; Bucci D; Carroll AJ; Baer MR; Wetzler M; Carter TH; Powell BL; Kolitz JE; Moore JO; Eisfeld AK; Blachly JS; Blum W; Caligiuri MA; Stone RM; Marcucci G; Croce CM; Byrd JC; Bloomfield CD
    Proc Natl Acad Sci U S A; 2014 Dec; 111(52):18679-84. PubMed ID: 25512507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic value of miR-29a expression in pediatric acute myeloid leukemia.
    Zhu C; Wang Y; Kuai W; Sun X; Chen H; Hong Z
    Clin Biochem; 2013 Jan; 46(1-2):49-53. PubMed ID: 22981932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of novel molecular markers for prognosis estimation of acute myeloid leukemia: over-expression of PDCD7, FIS1 and Ang2 may indicate poor prognosis in pretreatment patients with acute myeloid leukemia.
    Tian Y; Huang Z; Wang Z; Yin C; Zhou L; Zhang L; Huang K; Zhou H; Jiang X; Li J; Liao L; Yang M; Meng F
    PLoS One; 2014; 9(1):e84150. PubMed ID: 24416201
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High expression of inositol 1,4,5-trisphosphate receptor, type 2 (ITPR2) as a novel biomarker for worse prognosis in cytogenetically normal acute myeloid leukemia.
    Shi JL; Fu L; Wang WD
    Oncotarget; 2015 Mar; 6(7):5299-309. PubMed ID: 25779662
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of let-7a-2-3p or/and miR-188-5p as prognostic biomarkers in cytogenetically normal acute myeloid leukemia.
    Jinlong S; Lin F; Yonghui L; Li Y; Weidong W
    PLoS One; 2015; 10(2):e0118099. PubMed ID: 25646775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of RHOBTB2 aberration as an independent prognostic indicator in acute myeloid leukemia.
    Liu P; Ma Q; Chen H; Zhang L; Zhang X
    Aging (Albany NY); 2021 Jun; 13(11):15269-15284. PubMed ID: 34074803
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low miR-192 expression predicts poor prognosis in pediatric acute myeloid leukemia.
    Tian C; Zhang L; Li X; Zhang Y; Li J; Chen L
    Cancer Biomark; 2018; 22(2):209-215. PubMed ID: 29689705
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TET2 mutations improve the new European LeukemiaNet risk classification of acute myeloid leukemia: a Cancer and Leukemia Group B study.
    Metzeler KH; Maharry K; Radmacher MD; Mrózek K; Margeson D; Becker H; Curfman J; Holland KB; Schwind S; Whitman SP; Wu YZ; Blum W; Powell BL; Carter TH; Wetzler M; Moore JO; Kolitz JE; Baer MR; Carroll AJ; Larson RA; Caligiuri MA; Marcucci G; Bloomfield CD
    J Clin Oncol; 2011 Apr; 29(10):1373-81. PubMed ID: 21343549
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High VEGFC expression is associated with unique gene expression profiles and predicts adverse prognosis in pediatric and adult acute myeloid leukemia.
    de Jonge HJ; Valk PJ; Veeger NJ; ter Elst A; den Boer ML; Cloos J; de Haas V; van den Heuvel-Eibrink MM; Kaspers GJ; Zwaan CM; Kamps WA; Löwenberg B; de Bont ES
    Blood; 2010 Sep; 116(10):1747-54. PubMed ID: 20522712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High IL2RA mRNA expression is an independent adverse prognostic biomarker in core binding factor and intermediate-risk acute myeloid leukemia.
    Du W; He J; Zhou W; Shu S; Li J; Liu W; Deng Y; Lu C; Lin S; Ma Y; He Y; Zheng J; Zhu J; Bai L; Li X; Yao J; Hu D; Gu S; Li H; Guo A; Huang S; Feng X; Hu D
    J Transl Med; 2019 Jun; 17(1):191. PubMed ID: 31171000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression and prognostic significance of different mRNA 5'-end variants of the oncogene EVI1 in 266 patients with de novo AML: EVI1 and MDS1/EVI1 overexpression both predict short remission duration.
    Haas K; Kundi M; Sperr WR; Esterbauer H; Ludwig WD; Ratei R; Koller E; Gruener H; Sauerland C; Fonatsch C; Valent P; Wieser R
    Genes Chromosomes Cancer; 2008 Apr; 47(4):288-98. PubMed ID: 18181178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methylation-independent ITGA2 overexpression is associated with poor prognosis in de novo acute myeloid leukemia.
    Lian XY; Zhang W; Wu DH; Ma JC; Zhou JD; Zhang ZH; Wen XM; Xu ZJ; Lin J; Qian J
    J Cell Physiol; 2018 Dec; 233(12):9584-9593. PubMed ID: 30132837
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypermethylation of the GATA binding protein 4 (GATA4) promoter in Chinese pediatric acute myeloid leukemia.
    Tao YF; Fang F; Hu SY; Lu J; Cao L; Zhao WL; Xiao PF; Li ZH; Wang NN; Xu LX; Du XJ; Sun LC; Li YH; Li YP; Xu YY; Ni J; Wang J; Feng X; Pan J
    BMC Cancer; 2015 Oct; 15():756. PubMed ID: 26490736
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SCAMP2/5 as diagnostic and prognostic markers for acute myeloid leukemia.
    Yue C; Xie S; Zhong J; Zhao H; Lin Z; Zhang L; Xu B; Luo Y
    Sci Rep; 2021 Aug; 11(1):17012. PubMed ID: 34426610
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Expression and effect of neuropilin-1 in acute myeloid leukemic cells].
    Lu L; Zhang L; Xiao ZJ; Lu SH; Wang GS; Yang RC; Han ZC
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Dec; 15(6):1150-5. PubMed ID: 18088455
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NUP98/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern.
    Hollink IH; van den Heuvel-Eibrink MM; Arentsen-Peters ST; Pratcorona M; Abbas S; Kuipers JE; van Galen JF; Beverloo HB; Sonneveld E; Kaspers GJ; Trka J; Baruchel A; Zimmermann M; Creutzig U; Reinhardt D; Pieters R; Valk PJ; Zwaan CM
    Blood; 2011 Sep; 118(13):3645-56. PubMed ID: 21813447
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-106b~25 cluster is upregulated in relapsed MLL-rearranged pediatric acute myeloid leukemia.
    Verboon LJ; Obulkasim A; de Rooij JD; Katsman-Kuipers JE; Sonneveld E; Baruchel A; Trka J; Reinhardt D; Pieters R; Cloos J; Kaspers GJ; Klusmann JH; Zwaan CM; Fornerod M; van den Heuvel-Eibrink MM
    Oncotarget; 2016 Jul; 7(30):48412-48422. PubMed ID: 27351222
    [TBL] [Abstract][Full Text] [Related]  

  • 38. lncRNA co-expression network model for the prognostic analysis of acute myeloid leukemia.
    Pan JQ; Zhang YQ; Wang JH; Xu P; Wang W
    Int J Mol Med; 2017 Mar; 39(3):663-671. PubMed ID: 28204819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TAF15-ZNF384 fusion gene in childhood mixed phenotype acute leukemia.
    Yao L; Cen J; Pan J; Liu D; Wang Y; Chen Z; Ruan C; Chen S
    Cancer Genet; 2017 Feb; 211():1-4. PubMed ID: 28279306
    [No Abstract]   [Full Text] [Related]  

  • 40. Prognostic implication of expression of Angiopoietin-2 in acute myeloid leukemia.
    Fiedler W; Schuch G; Loges S
    Leuk Res; 2008 Jun; 32(6):843-4. PubMed ID: 18207236
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.